Search results
Results from the Tech24 Deals Content Network
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bristol Myers Squibb wasn’t one of them. The 10 stocks that ...
For premium support please call: 800-290-4726 more ways to reach us
Friday, Bristol Myers Squibb & Co (NYSE:BMY) posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for ...
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Motley Fool Transcribing, The Motley Fool. July 26, 2024 at 11:30 AM. Logo of jester cap with thought bubble. Image source: The Motley Fool. Bristol Myers Squibb (NYSE: BMY) Q2 2024 Earnings Call ...
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
Bristol Myers Squibb: A high-yield dividend stock with an attractive valuation. Bristol Myers Squibb, or BMS for short, is another well-established pharmaceutical company with a strong presence in ...
Michael Erman. July 26, 2024 at 9:11 AM. By Michael Erman. (Reuters) - Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like ...